Work

Abstract PS1-12-29: Real-world outcomes of second-line therapies in HR+/HER2- metastatic breast cancer after progression on CDK4/6 inhibitor

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-12-29

Authors: A. PEINOIT, F. LE BORGNE, J. FRENEL, L. MATHIOT, F. BOCQUET, A. PATSOURIS, M. ROBERT, E. BULTOT, J. QUINTIN, V. SIMMET, M. CAMPONE

Institution: Institut de Cancérologie de l'Ouest

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129238188

Cites:

Cited by:

Related to: